| Akiko Saberi, MD | |
|
2101 Elm St N, Vamc, Fargo, ND 58102-2417 | |
| (701) 232-3241 | |
| Not Available |
| Full Name | Akiko Saberi |
|---|---|
| Gender | Female |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 2101 Elm St N, Fargo, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588604326 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 4635 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Akiko Saberi, MD 2925 Peterson Pkwy Ne, Fargo, ND 58102-1752 Ph: () - | Akiko Saberi, MD 2101 Elm St N, Vamc, Fargo, ND 58102-2417 Ph: (701) 232-3241 |
News Archive
Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, announced today that Abbie Celniker, Ph.D., CEO of Taligen Therapeutics was among the recipients of the Mass High Tech, Voice of New England Innovation, 2010 All-Star Awards. The All-Star Awards recognize 16 dynamic and influential leaders of New England's innovation economy. This is the 15th year of the awards program.
Noting that former Secretary of State Hillary Clinton in June 2012 "announced a new partnership to address the persistent burden of maternal mortality, called Saving Mothers, Giving Life," which aims "to reduce maternal mortality by 50 percent in eight districts in Zambia and Uganda in just one year," Karen Grepin, assistant professor of global health policy at New York University's Robert F. Wagner Graduate School of Public Service, writes in her "Global Health Blog,"
Arvinas LLC, a private biotechnology company creating a new class of drugs based on protein degradation, announced a strategic collaboration with Merck, known as MSD outside of the United States and Canada, in which Arvinas' novel PROTAC technology will be used to degrade target proteins, with the goal of creating novel therapeutics.
Blood is in big demand at the University of Alabama at Birmingham Hospital, once the fourth largest user of blood among U.S. hospitals served by the American Red Cross. And although blood transfusions can be life-saving during cancer care, trauma, surgery, transplants and difficult pregnancies, supply doesn't always rise to meet demand.
...a discovery that could help in the design of more targeted treatments for patients with various lung diseases, including cystic fibrosis.
› Verified 6 days ago
Mr. Zhanyong Bing, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-2000 | |
Roland Lass, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 2101 Elm St N, Fargo, ND 58102 Phone: 701-239-3700 Fax: 701-237-2646 | |
Dr. John Joseph Evans, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-2000 Fax: 701-234-2345 | |
Joshua Leclaire, D.O. Pathology Medicare: Accepting Medicare Assignments Practice Location: 2101 Elm St N, Fargo, ND 58102 Phone: 701-239-3700 | |
Julie A Marsh, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-2350 Fax: 701-234-7378 | |
Terrence E Grimm, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-2401 Fax: 701-234-7378 | |
Dr. Hong Qi Peng, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 Broadway N, Fargo, ND 58102 Phone: 701-234-2469 |